Voloridge Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-11,933
| Closed | -$128K | – | 1683 |
|
2021
Q3 | $128K | Buy |
+11,933
| New | +$128K | ﹤0.01% | 1604 |
|
2020
Q4 | – | Sell |
-48,814
| Closed | -$723K | – | 1426 |
|
2020
Q3 | $723K | Buy |
+48,814
| New | +$723K | 0.01% | 1019 |
|
2020
Q1 | – | Sell |
-168,614
| Closed | -$3.96M | – | 1220 |
|
2019
Q4 | $3.96M | Buy |
168,614
+143,683
| +576% | +$3.38M | 0.08% | 331 |
|
2019
Q3 | $461K | Sell |
24,931
-45,086
| -64% | -$834K | 0.01% | 824 |
|
2019
Q2 | $1.3M | Buy |
+70,017
| New | +$1.3M | 0.04% | 401 |
|
2018
Q3 | – | Sell |
-21,227
| Closed | -$825K | – | 369 |
|
2018
Q2 | $825K | Sell |
21,227
-81,627
| -79% | -$3.17M | 0.02% | 332 |
|
2018
Q1 | $2.84M | Buy |
+102,854
| New | +$2.84M | 0.07% | 238 |
|
2015
Q4 | – | Sell |
-52,500
| Closed | -$1.28M | – | 236 |
|
2015
Q3 | $1.28M | Sell |
52,500
-36,658
| -41% | -$894K | 0.06% | 207 |
|
2015
Q2 | $2.78M | Buy |
+89,158
| New | +$2.78M | 0.14% | 152 |
|